Effects of A2 type botulinum toxin on spontaneous miniature and evoked transmitter release from the rat spinal excitatory and inhibitory synapses

Toxicon

Volumn 56, Issue 8, 2010, Pages 1315-1326

  Akaike, Norio ^a   Ito, Yushi ^a   Shin, Min Chul ^a   Nonaka, Kiku ^a   Torii, Yasushi ^b   Harakawa, Tetsuhiro ^b   Ginnaga, Akihiro ^b   Kozaki, Shunji ^c   Kaji, Ryuji ^d  

^a KUMAMOTO HEALTH SCIENCE UNIVERSITY   (Japan)

^b Kaketsuken   (Japan)

^c Osaka Prefecture University   (Japan)

^d UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

A2NTX; Botulinum toxin; Evoked IPSC and EPSC; Focal electrical stimulation; Miniature IPSC and EPSC; Spinal nerve ending

Indexed keywords

4 AMINOBUTYRIC ACID; BOTULINUM TOXIN A; BOTULINUM TOXIN A2; CALCIUM ION; GLUTAMIC ACID; GLYCINE; POTASSIUM ION; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ELECTROSTIMULATION; EXCITATORY JUNCTION POTENTIAL; GABAERGIC TRANSMISSION; NONHUMAN; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; RAT; SPINAL CORD NERVE CELL; SYNAPTIC TRANSMISSION;

ANIMALS; BOTULINUM TOXINS, TYPE A; CALCIUM CHANNELS; EVOKED POTENTIALS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; GLYCINE; NEUROTOXINS; PATCH-CLAMP TECHNIQUES; PRESYNAPTIC TERMINALS; RATS; RATS, WISTAR; SPINAL CORD; SYNAPTIC TRANSMISSION;

RATTUS;

EID: 77958501111     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2010.07.015     Document Type: Article

References (46)

1. Akaike N., Harata N. Nystatin perforated patch recording and its applications to analyses of intracellular mechanisms. Jpn. J. Physiol. 1994, 44:433-473.
2. Akaike N., Murakami N., Katsurabayashi S., Jin Y.H., Imazawa T. Focal stimulation of single GABAergic presynaptic boutons on the rat hippocampal neuron. Neurosci. Res. 2002, 42:187-195.
3. Akaike N., Moorhouse A.J. Techniques: applications of the nerve-bouton preparation in neuropharmacology. Trends Pharmacol. Sci. 2003, 24:44-47.
4. Antonucci F., Rossi C., Gianfranceschi L., Rossetto O., Caleo M. Long-distance retrograde effects of botulinum neurotoxin A. J. Neurosci. 2008, 28:3689-3696.
5. Ashton A.C., Dolly J.O. Characterization of the inhibitory action of botulinum neurotoxin type A on the release of several transmitters from rat cerebrocortical synaptosomes. J. Neurochem. 1988, 50:1808-1816.
6. Augustin I., Rosenmund C., Südhof T.C., Brose N. Munc 13-1 is essential for fusion competence of glutamatergic synaptic vesicles. Nature 1999, 400:457-461.
7. 2+ concentration to SNARE-mediated membrane fusion. Mol. Biol. Cell. 2005, 16:4755-4764.
8. 2-domain proteins. J. Biol Cem 1995, 207:25273-25280.
9. 2+ partially rescues synaptic transmission in hippocampal cultures treated with botulinum toxin A and C, but not tetanus toxin. J. Neurosci. 1997, 17:7190-7202.
10. Casale R., Tugnoli V. Botulinum toxin for pain. Drugs R D 2008, 9:11-27.
11. Costantin L., Bozzi Y., Richichi C., Viegi A., Antonucci F., Funicello M., Gobbi M., Mennini T., Rossetto O., Montecucco C., Maffei L., Vezzani A., Caleo M. Antiepileptic effects of botulinum neurotoxin E. J. Neurosci. 2005, 25:1943-1951.
12. Davletov B., Bajohrs M., Binz T. Beyond BOTOX: advantages and limitations of individual botulinum neurotoxins. Trends Neurosci. 2005, 28:446-452.
13. Dong M., Yeh F., Tepp W.H., Dean C., Johnson E.A., Janz R., Chapman E.R. SV2 is the protein receptor for botulinum neurotoxin A. Science 2006, 312:592-596.
14. Fischer A., Montal M. Single molecule detection of intermediates during botulinum neurotoxin translocation across membranes. Proc. Natl. Acad. Sci. U S A 2007, 104:10447-10452.
15. 2+ sensor for transmitter release at a central synapse. Cell 1994, 79:717-727.
16. Goto Y., Torii Y., Nakahira S., Harakawa T., Ginnaga A., Takahashi M., Sakamoto T., Kozaki S., Kaji R., 2008. The therapeutic window in rats of botulinum neurotoxin subtype A2 is wider than that of subtype A1, regardless of the presence of nontoxic proteins. Int. Conf. 2008, Supplement 1 (51), 12.
17. Gundersen C.B., Katz B., Miledi R. The antagonism between botulinum toxin and calcium in motor nerve terminals. Proc. R Soc. Lond B. Biol. Sci. 1982, 216:369-376.
18. Jang I.S., Rhee J.S., Watanabe T., Akaike N., Akaike N. Histaminergic modulation of GABAergic transmission in rat ventromedial hypothalamic neurons. J. Physiol. 2001, 534:791-803.
19. Jeynes L.C., Gauci C.A. Evidence for the use of botulinum toxin in the chronic pain setting - a review of the literature. Pain Pract. 2008, 8:269-276.
20. Johnson E.A. Clostridial toxins as therapeutic agents: benefits of nature's most toxic proteins. Annu. Rev. Microbiol. 1999, 53:551-575.
21. Katsurabayashi S., Kubota H., Moorhouse A.J., Akaike N. Differential modulation of evoked and spontaneous glycine release from rat spinal cord glycinergic terminals by the cyclic AMP/protein kinase A transduction cascade. J. Neurochem. 2004, 91:657-666.
22. Klein A.W., Carruthers A., Fagien S., Lowe N.J. Comparisons among botulinum toxins: an evidence-based medicine review. Plast. Reconstr. Surg. 2008, 121:413e-422e.
23. Lalli G., Bohnert S., Deinhardt K., Verastegui C., Schiavo G. The journey of tetanus and botulinum neurotoxins in neurons. Trends Microbiol. 2003, 11:431-437.
24. Maeda M., Tanaka E., Shoudai K., Nonaka K., Murayama N., Ito Y., Akaike N. Differential effects of divalent cations on spontaneous and evoked glycine release from spinal interneurons. J. Neurophysiol. 2009, 101:1103-1113.
25. Mahrhold S., Rummel A., Bigalke H., Davletov B., Binz T. The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves. FEBS Lett. 2006, 580:2011-2014.
26. Montecucco C., Molgo J. Botulinal neurotoxins: revival of an old killer. Curr. Opin. Pharmacol. 2005, 5:274-279.
27. Nakahira, S., Munechika, S., Itai, S., Goto, Y., Torii, Y., Kozaki, S., Harakawa, T., Ginnaga, A., 2008. Comparison of immunogenicity between LL toxin from subtype A1 and NTX from subtype A2. Int. Conf. 2008, Supplement 1 (51), 16.
28. Pellizzari R., Rossetto O., Schiavo G., Montecucco C. Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses. Philos. Trans. R Soc. Lond B. Biol. Sci. 1999, 354:259-268.
29. Rhee J.S., Ishibashi H., Akaike N. Calcium channels in the GABAergic presynaptic nerve terminals projecting to meynert neurons of the rat. J. Neurochem. 1999, 72:800-807.
30. Rizo J., Südhof T.C. Progress in membrane fusion: from structure to function. Nat. Struc. Biol. 1998, 5:839-842.
31. 2+-dependent binding of synaptotagmin to SNARE complexes. J. Biol. Chem. 2000, 275:6328-6336.
32. Rummel A., Eichner T., Weil T., Karnath T., Gutcaits A., Mahrhold S., Sandhoff K., Proia R.L., Acharya K.R., Bigalke H., Binz T. Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept. Proc. Natl. Acad. Sci. U S A 2007, 104:359-364.
33. Sakaguchi G., Oishi I., Kozaki S. Purification and oral toxicities of clostridium botulinum progenitor toxins. Biomedical Aspects of Botulism 1981, 21-34. Academic Press, New York. G.E. Lewis (Ed.).
34. Schiavo G., Matteoli M., Montecucco C. Neurotoxins affecting neuroexocytosis. Physiol. Rev. 2000, 80:717-766.
35. Schikorski T., Stevens C.F. Morphological correlates of functionally defined synaptic vesicle populations. Nat. Neurosci. 2001, 4:391-395.
36. A receptor by intracellular ATP in dissociated nucleus tractus solitarii neurones of rat. J. Physiol. 1992, 449:551-572.
37. + channel blockers on spontaneous glycine release atrat spinal neuron. Brain Res. 2007, 1157:11-22.
38. Simpson L.L. Identification of the major steps in botulinum toxin action. Annu. Rev. Pharmacol. Toxicol. 2004, 44:167-193.
39. Söllner T.H. Regulated exocytosis and SNARE fusion. Mol. Membr. Bio. 2003, 20:209-220.
40. Südhof T.C. The synaptic vesicle cycle. Annu. Rev. Neurosci. 2004, 27:509-547.
41. Südhof T.C., Scheller R.H. Mechanism and regulation of neurotransmitter release. Synapses 2003, 177-216. The Johns Hopkins University Press, Baltimore/London. W.M. Cowan, T.C. Südhof, C.F. Stevens (Eds.).
42. Torii Y., Kiyota N., Mori Y., Nakahira S., Harakawa T., Kozaki S., Ginnaga A. Comparison of botulinum toxin type A preparations in the grip strength of rats. Int. Conf. 2008, Supplement 2008, 1(51):22.
43. 2+-regulated membrane fusion by synaptotagmin and SNAREs. Science 2004, 304:435-438.
44. Varoqueaux F., Sigler A., Rhee J.S., Brose N., Enk C., Reim K., Rosenmund C. Total arrest of spontaneous and evoked synaptic transmission but normal synaptogenesis in the absence of Munc13-mediated vesicle priming. Proc. Natl. Acad. Sci. U S A 2002, 99:9037-9042.
45. Verderio C., Grumelli C., Raiteri L., Coco S., Paluzzi S., Caccin P., Rossetto O., Bonanno G., Montecucco C., Matteoli M. Traffic of botulinum toxins A and E in excitatory and inhibitory neurons. Traffic 2007, 8:142-153.
46. 2+-sensor for spontaneous release. Nat. Neurosci. 2009, 12:756-766.